Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A Real American President: Donald Trump -- Ignore unavailable to you. Want to Upgrade?

To: bruwin who wrote (201316)	4/25/2020 6:47:38 PM
From: FJB	4 Recommendations Recommended By alanrs Honey_Bee locogringo Stock Puppy Read Replies (1) \| Respond to of 456349

China filed a patent for US drug that has helped some coronavirus patients recover the day after it confirmed bug could infect humans, adding to concerns about global cover-up Daily Mail (UK), by Ian Birrell Original Article China filed a patent for a drug seen as one of the best potential weapons against coronavirus the day after it confirmed human transmission of the disease. The revelation that it moved so fast fuels concerns about a cover-up of the pandemic when it erupted in Wuhan last year, and suggests that China’s understanding of the virus was far advanced from the impression given by its public stance.(Snip) The application was made by Wuhan Institute of Virology, the top-secret bio-laboratory at the centre of concerns about a possible leak of the disease from its research on bats, and the country’s Military Medicine Institute.